PURPOSE: Head and neck cancer (HNC) survivors have substantial psychological distress in addition to treatment-related side effects. This study examines the long-term quality of life (QOL) of HNC survivors in a busy tertiary care center. MATERIAL AND METHODS: A prospective, cross-sectional survey was conducted studying 212 HNC survivors 1 year after completion of their treatment at a tertiary cancer center. Quality of life assessments were performed using the 2 standardized health-related QOL questionnaires: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 and The Quality of Life Questionnaire Head and Neck Cancer Module. RESULTS: The overall global QOL rating for the study cohort was satisfactory. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 scores showed that the domains where most patients faired poorly included financial difficulties (54%), appetite loss (36%), fatigue (33%), and cough (30%). The Quality of Life Questionnaire Head and Neck Cancer Module scale identified the domains with poor scores to be dry mouth (64%), dental problems (42%), sticky saliva (40%), cough (39%), and problems with mouth opening (32%). Patients with early-stage tumors and those treated with surgery alone had significantly better QOL scores when compared with advanced stage tumors and patients receiving either radiation alone or multimodality treatment, respectively. CONCLUSIONS: Quality of life questionnaires provide a medium for patients to effectively communicate with their physician in a busy tertiary care facility and provide an insight into the physical, psychological, and social problems affecting our patients which can then direct future interventions.
PURPOSE: Head and neck cancer (HNC) survivors have substantial psychological distress in addition to treatment-related side effects. This study examines the long-term quality of life (QOL) of HNC survivors in a busy tertiary care center. MATERIAL AND METHODS: A prospective, cross-sectional survey was conducted studying 212 HNC survivors 1 year after completion of their treatment at a tertiary cancer center. Quality of life assessments were performed using the 2 standardized health-related QOL questionnaires: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 and The Quality of Life Questionnaire Head and Neck Cancer Module. RESULTS: The overall global QOL rating for the study cohort was satisfactory. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 scores showed that the domains where most patients faired poorly included financial difficulties (54%), appetite loss (36%), fatigue (33%), and cough (30%). The Quality of Life Questionnaire Head and Neck Cancer Module scale identified the domains with poor scores to be dry mouth (64%), dental problems (42%), sticky saliva (40%), cough (39%), and problems with mouth opening (32%). Patients with early-stage tumors and those treated with surgery alone had significantly better QOL scores when compared with advanced stage tumors and patients receiving either radiation alone or multimodality treatment, respectively. CONCLUSIONS: Quality of life questionnaires provide a medium for patients to effectively communicate with their physician in a busy tertiary care facility and provide an insight into the physical, psychological, and social problems affecting our patients which can then direct future interventions.
Authors: Namie Okino Sawada; Juliana Maria de Paula; Helena Megumi Sonobe; Marcia Maria Fontão Zago; Giselle Patricia Guerrero; Adriana Cristina Nicolussi Journal: Support Care Cancer Date: 2012-11 Impact factor: 3.603
Authors: Jane Turner; Patsy Yates; Lizbeth Kenny; Louisa G Gordon; Bryan Burmeister; Brett G M Hughes; Alexandra L McCarthy; Chris Perry; Raymond J Chan; Alana Paviour; Helen Skerman; Martin Batstone; Lisa Mackenzie Journal: Support Care Cancer Date: 2019-04-02 Impact factor: 3.603
Authors: K Collie; J McCormick; A Waller; C Railton; L Shirt; J Chobanuk; A Taylor; H Lau; D Hao; B Walley; B Kapusta; A A Joy; L E Carlson; J Giese-Davis Journal: Curr Oncol Date: 2014-02 Impact factor: 3.677
Authors: Matthew C Perez; Daniel E Oliver; Evan S Weitman; David Boulware; Jane L Messina; Javier Torres-Roca; C Wayne Cruse; Ricardo J Gonzalez; Amod A Sarnaik; Vernon K Sondak; Evan J Wuthrick; Louis B Harrison; Jonathan S Zager Journal: Ann Surg Oncol Date: 2018-10-11 Impact factor: 5.344
Authors: Puja Aggarwal; Katherine A Hutcheson; Ryan P Goepfert; Adam S Garden; Naveen Garg; Frank E Mott; Clifton D Fuller; Stephen Y Lai; Gary Brandon Gunn; Mark S Chambers; Ehab Y Hanna; Erich M Sturgis; Sanjay Shete Journal: Head Neck Date: 2022-01-27 Impact factor: 3.147
Authors: Sylvia L Crowder; Katherine G Douglas; M Yanina Pepino; Kalika P Sarma; Anna E Arthur Journal: J Cancer Surviv Date: 2018-03-20 Impact factor: 4.442
Authors: Winnie K W So; K C Choi; Joanne M T Chen; Carmen W H Chan; S Y Chair; Olivia W M Fung; Rayman W M Wan; Suzanne S S Mak; W M Ling; W T Ng; Bernice W L Yu Journal: Support Care Cancer Date: 2014-05-20 Impact factor: 3.603